From Name:
From Email:
To Name:
To Email:

Optional Message:

Roche will work with Oryzon on cancer-suppressing genes

from Bloomberg

Roche Holding AG agreed to buy the rights from Spain's Oryzon Genomics SA to an experimental drug that's meant to switch on genes that block the growth of cancer, a new area in the crowded field of potential oncology therapies. Roche will pay Barcelona-based Oryzon $21 million up front and for meeting near-term targets, plus payments that may exceed $500 million if the drug meets other goals. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063